Urinary Porphyrins in Autism Spectrum Disorders

  • Janet K. Kern
  • David A. Geier
  • Lisa Sykes
  • Mark Geier


Measuring toxic metal body burden is particularly important in autism spectrum disorder (ASD) because evidence indicates that children with ASD have a greater susceptibility to heavy-metal intoxication than typically developing children. The more traditional laboratory tests used to measure toxic metal levels in ASD provide a snapshot of current exposure but do not necessarily provide a measure of tissue body burden. A more recent approach is to use urinary porphyrins which provide an indirect measure of toxic metal body burden. Urinary porphyrins are not a direct measure of toxic metals in the urine but a measure of tissue body burden by the level of disruption of the heme synthesis pathway caused by the presence of toxic metals in the tissues. Recent evidence suggests that the levels of mercury-associated porphyrins are different in children with ASD as compared to controls, with significantly increased levels of pentacarboxyporphyrin (5cxP), precoproporphyrins (prcP), and coproporphyrins (cP). In addition, there is a significant relationship between the severity of the child’s autism symptoms and the elevation of mercury-associated urinary porphyrins (i.e., the higher the mercury-associated porphyrins, the more severely affected the child). The mercury-associated porphyrins can be lowered with chelation therapy, and porphyrin profile testing can be used in clinical medicine in the targeted treatment of heavy-metal toxicity.


Autism Spectrum Disorder Autism Spectrum Disorder Body Burden Chelation Therapy Autism Symptom Severity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Adams JB, Baral M, Geis E, et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol. 2009;532–640.Google Scholar
  2. Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8:34.CrossRefGoogle Scholar
  3. Austin DW, Shandley K. An investigation of porphyrinuria in Australian children with autism. J Toxicol Environ Health. 2008;71:1349–51.CrossRefGoogle Scholar
  4. Baker S. Detoxification and healing. New Canaan: Keats Publishing; 1997.Google Scholar
  5. Begerow J, Zander D, Freier I, et al. Long-term mercury excretion in urine after removal of amalgam fillings. Int Arch Occup Environ Health. 1994;66:209–12.PubMedCrossRefGoogle Scholar
  6. Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem Res. 2012;37(8):1681–9.PubMedCrossRefGoogle Scholar
  7. Cianciola ME, Echeverria D, Martin MD, et al. Epidemiologic assessment of measures used to indicate low-level exposure to mercury vapor (Hg). J Toxicol Environ Health. 1997;52:19–33.PubMedGoogle Scholar
  8. Desoto MC, Hitlan RT. Sorting out the spinning of autism: heavy metals and the question of incidence. Acta Neurobiol Exp (Wars). 2010;70:165–76.PubMedGoogle Scholar
  9. Echeverria D, Heyer NJ, Martin MD, et al. Behavioral effects of low-level exposure to elemental Hg among dentists. Neurotoxicol Teratol. 1995;17:161–8.CrossRefGoogle Scholar
  10. Echeverria D, Woods JS, Heyer NJ, et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicol Teratol. 2005;27:781–96.PubMedCrossRefGoogle Scholar
  11. Elsheshtawy E, Tobar S, Sherra K, et al. Study of some biomarkers in hair of children with autism. Middle East Curr Psychiatry. 2011;18:6–10.CrossRefGoogle Scholar
  12. Falnoga I, Tusek-Znidaric M, Horvat M, et al. Mercury, selenium, and cadmium in human autopsy samples from Idrija residents and mercury mine workers. Environ Res. 2000;84:211–8.PubMedCrossRefGoogle Scholar
  13. Fowler BA. Porphyrinurias induced by mercury and other metals. Toxicol Sci. 2001;61:197–8.PubMedCrossRefGoogle Scholar
  14. Frith U. Autism: explaining the enigma. Oxford: Blackwell; 1997.Google Scholar
  15. Garcia-Vargas GG, Del Razo LM, Cebrian ME, et al. Altered urinary porphyrin excretion in a human population chronically exposed to arsenic in Mexico. Hum Exp Toxicol. 1994;13:839–47.PubMedCrossRefGoogle Scholar
  16. Geier DA, Geier MR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res. 2006a;66:182–8.PubMedCrossRefGoogle Scholar
  17. Geier DA, Geier MR. A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res. 2006b;10:57–64.PubMedCrossRefGoogle Scholar
  18. Geier DA, Geier MR. A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health. 2007;70:1723–30.CrossRefGoogle Scholar
  19. Geier DA, Kern JK, Adams JB, et al. A prospective study of oxidative stress biomarkers in autistic disorders. J Applied Psychol. 2009a;5:2–10.CrossRefGoogle Scholar
  20. Geier DA, Kern JK, Geier MR. A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders. J Toxicol Environ Health A. 2009b;72:1585–91.PubMedCrossRefGoogle Scholar
  21. Geier DA, Kern JK, Garver CR, et al. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci. 2009c;280:101–8.PubMedCrossRefGoogle Scholar
  22. Geier DA, Carmody T, Kern JK, et al. A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children’s dental amalgam trial. Biometals. 2011;24:215–24.PubMedCrossRefGoogle Scholar
  23. Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, et al. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther. 1995;272:264–74.PubMedGoogle Scholar
  24. Gutman J. Glutathione – your bodies most powerful protector. 3rd ed. Montreal: Communications kudoca; 2002.Google Scholar
  25. Heyer NJ, Bittner AC Jr, Echeverria D, et al. A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production. Toxicol Lett. 2006;161:159–66.PubMedCrossRefGoogle Scholar
  26. Heyer NJ, Echeverria D, Woods JS. Disordered porphyrin metabolism: a potential biological marker for autism risk assessment. Autism Res. 2012;5:84–92.PubMedCrossRefGoogle Scholar
  27. Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol. 2003;22:277–85.PubMedCrossRefGoogle Scholar
  28. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611–7.PubMedGoogle Scholar
  29. James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:947–56.PubMedCrossRefGoogle Scholar
  30. James SJ, Rose S, Melnyk S, et al. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J. 2009;23:2374–83.PubMedCrossRefGoogle Scholar
  31. Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B. 2006;9:485–99.CrossRefGoogle Scholar
  32. Kern JK, Waring RH, Ramsden DB, et al. Abnormal sulfation chemistry in autism. In: Columbus F, editor. Progress in autism research. Hauppauge: Nova Science; 2004.Google Scholar
  33. Kern JK, Trivedi MH, Garver CR, et al. The pattern of sensory processing abnormalities in autism. Autism. 2006;10:480–94.PubMedCrossRefGoogle Scholar
  34. Kern JK, Geier DA, Adams JB, et al. A Biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autistic disorders. Biometals. 2010;23:1043–51.PubMedCrossRefGoogle Scholar
  35. Kern JK, Geier DA, Adams JB, et al. Toxicity biomarkers related to autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr Int. 2011;53:147–53.PubMedCrossRefGoogle Scholar
  36. Lakshmi Priya MD, Geetha A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res. 2011;142:148–58.PubMedCrossRefGoogle Scholar
  37. Majewska MD, Urbanowicz E, Rok-Bujko P, et al. Age-dependent lower or higher levels of hair mercury in autistic children than in healthy controls. Acta Neurobiol Exp (Wars). 2010;70:196–208.Google Scholar
  38. Nasiadek M, Chmielnicka J, Subdys J. Analysis of urinary porphyrins in rats exposed to aluminum and iron. Ecotoxicol Environ Saf. 2001;48:11–7.PubMedCrossRefGoogle Scholar
  39. Nataf R, Skorupka C, Amet L, et al. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Applied Pharmacol. 2006;14:99–108.CrossRefGoogle Scholar
  40. Nataf R, Skorupka C, Lam A, et al. Porphyrinuria in childhood autistic disorder is not associated with urinary creatinine deficiency. Pediatr Int. 2008;50:528–32.PubMedCrossRefGoogle Scholar
  41. Ng JC, Wang JP, Zheng B, et al. Urinary porphyrins as biomarkers for arsenic exposure among susceptible populations in Guizhou province, China. Toxicol Appl Pharmacol. 2005;206:176–84.PubMedCrossRefGoogle Scholar
  42. Paşca SP, Dronca E, Kaucsár T, et al. One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med. 2009;13:4229–38.PubMedCrossRefGoogle Scholar
  43. Pingree SD, Simmonds PL, Rummel KT, et al. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats. Toxicol Sci. 2001a;61:234–40.PubMedCrossRefGoogle Scholar
  44. Pingree SD, Simmonds PL, Woods JS. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol Sci. 2001b;61:224–33.PubMedCrossRefGoogle Scholar
  45. Rimland B, Edelson M. Autism treatment evaluation checklist. San Diego: Autism Research Institute; 1999. www.ARI-ATEC.com and https://www.autismeval.com/ari-atec/report1.html.
  46. Rose S, Melnyk S, Savenka A, et al. The frequency of polymorphisms affecting lead and mercury toxicity among children with autism. Am J Biochem Biotechnol. 2008;4:85–94.CrossRefGoogle Scholar
  47. Schopler E, Reichler RJ, Renner BR. The Childhood Autism Rating Scale. Los Angeles: Western Psychological Services; 1994. p. 90025–1251.Google Scholar
  48. Wang L, Angley MT, Gerber JP, et al. A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers. 2011;16:537–52.PubMedCrossRefGoogle Scholar
  49. Waring RH, Klovrza LV. Sulphur metabolism in autism. J Nutr Environ Med. 2000;10:25–32.CrossRefGoogle Scholar
  50. Woods JS. Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity. Can J Physiol Pharmacol. 1996;74:210–5.PubMedGoogle Scholar
  51. Woods JS, Fowler BA. Renal porphyrinuria during chronic methyl mercury exposure. J Lab Clin Med. 1977;90:266–72.PubMedGoogle Scholar
  52. Woods JS, Bowers MA, Davis HA. Urinary porphyrin profiles as biomarkers of trace metal exposure and toxicity: studies on urinary porphyrin excretion patterns in rats during prolonged exposure to methyl mercury. Toxicol Appl Pharmacol. 1991;110:464–76.PubMedCrossRefGoogle Scholar
  53. Woods JS, Martin MD, Naleway CA, et al. Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor. J Toxicol Environ Health. 1993;40:235–46.PubMedCrossRefGoogle Scholar
  54. Woods JS, Martin MD, Leroux BG, et al. Urinary porphyrin excretion in normal children and adolescents. Clin Chim Acta. 2009;405:104–9.PubMedCrossRefGoogle Scholar
  55. Woods JS, Armel SE, Fulton DI, et al. Urinary porphyrin excretion in neurotypical and autistic children. Environ Health Perspect. 2010;118:450–7.CrossRefGoogle Scholar
  56. Youn SI, Jin SH, Kim SH, et al. Porphyrinuria in Korean children with autism: correlation with oxidative stress. J Toxicol Environ Health A. 2010;73:701–10.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Janet K. Kern
    • 1
  • David A. Geier
    • 1
  • Lisa Sykes
    • 2
  • Mark Geier
    • 1
  1. 1.The Institute of Chronic Illnesses, IncSilver SpringUSA
  2. 2.The Coalition for Mercury-free Drugs (CoMeD, Inc.)RichmondUSA

Personalised recommendations